Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst — priced at more than $18,000 for a 28-day supply — only because of the generosity of patient assistance foundations. Clark, 57, a former insurance agent who lives in Bixby, Oklahoma, had to stop working in 2015 and go on Social Security disability and ...
The American Benefits Council (ABC) issued a release outlining what payers should expect legislatively post-election including COVID-19 relief and stimulus legislation, Affordable Care Act expansion, and other efforts to ensure Americans have access to the coverage they need. “Without the support of a fully Democratic Congress, President-elect Biden’s broad health plan will be largely stalled,” the release ...
2020 was a year dominated by the fallout from a generational global pandemic. So perhaps it's no surprise that COVID-19 headlines also governed much of our coverage over the course of this year, as we shared the latest on how the coronavirus pandemic was impacting you.
In the recent "IDC FutureScape: Worldwide Health Industry 2021 Predictions" report, experts at IDC Health Insights offer their thoughts about the issues healthcare and life science organizations will contend with over the next year and beyond.
Under the proposed rule, providers would be able to disclose patient data if they believe it's in the patient's best interest.
Increases in spending on hospital care, physician services and prescription drugs squeezed U.S. commercial health insurers in 2019, according to new federal government health spending data.
Pfizer said Wednesday it will supply the U.S. government with an additional 100 million doses of its COVID-19 vaccine under a new agreement between the pharmaceutical giant and the Trump administration. Pfizer and its German partner BioNTech said that will bring their total current commitment to 200 million doses for the U.S. That should be ...
The Senate voted in the wee hours of Tuesday morning to repeal insurers’ federal antitrust enforcement immunity, sending the bill to the president’s desk. The Competitive Health Insurance Reform Act would amend the 1945 McCarran-Ferguson Act, which gave insurers federal immunity from antitrust enforcement and delegated primary authority to regulate consolidation in the insurance industry. ...
Congress at last passed a second stimulus bill this week — as of this writing, it is still awaiting President Trump's signature — and it includes a second round of PPP loans for affected small businesses as well as loan-forgiveness rule changes that are favorable to PPP borrowers.
A long-discussed surprise medical billing fix will be part of the congressional budget deal that includes $900 billion in new COVID-19 relief.